Page last updated: 2024-08-16

propranolol and methylnitrosourea

propranolol has been researched along with methylnitrosourea in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cernackova, A; Horvathova, L; Macejova, D; Mravec, B; Tibensky, M; Tillinger, A	1

Other Studies

1 other study(ies) available for propranolol and methylnitrosourea

Article	Year
Chronic propranolol treatment moderately attenuated development of N-methyl-N-nitrosourea-induced mammary carcinoma in female rats. Anti-cancer drugs, 2021, 11-01, Volume: 32, Issue:10 Topics: Adrenergic beta-Antagonists; Animals; Caspase 3; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Methylnitrosourea; Phenylethanolamine N-Methyltransferase; Propranolol; Proto-Oncogene Proteins c-fos; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Tumor Microenvironment; Tyrosine 3-Monooxygenase	2021

Article

Year

Chronic propranolol treatment moderately attenuated development of N-methyl-N-nitrosourea-induced mammary carcinoma in female rats.

Anti-cancer drugs, 2021, 11-01, Volume: 32, Issue:10

Topics: Adrenergic beta-Antagonists; Animals; Caspase 3; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Methylnitrosourea; Phenylethanolamine N-Methyltransferase; Propranolol; Proto-Oncogene Proteins c-fos; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Tumor Microenvironment; Tyrosine 3-Monooxygenase

2021